Tag Archives: The State of Patent Eligibility

In re: Board of Trustees of Stanford: “Big Data” Personalized Medicine is an Abstract Idea

Posted on March 12, 2021 by Warren Woessner

In re: Board of Trustees of the Leland Stanford Junior University, Appeal no. 2020-1012 (Federal Circuit, March 11, 2021) a three judge panel of Prost, Lurie and Reyna affirmed the ruling by the Board of Appeals that the claims of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment

XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa

Posted on September 8, 2020 by Warren Woessner

In XY v. Trans Ova Genetics, Inc., Appeal No. 2019-1789 (Fed. Cir. July 31, 2020), a panel of Wallach, Plager and Stoll reversed the district court’s finding that claims to an improved method of cell sorting are patent ineligible under … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”

Posted on August 14, 2020 by Warren Woessner

This post will briefly discuss the Fed. Cir.’s denial of rehearing en banc – which  left the modified panel opinion stand. The lengthy panel opinion has been the subject of my last three posts, and you should read them before … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

CardioNet v. Infobionics: The Requirement for Improvements in Patent Eligibility

Posted on April 20, 2020 by Warren Woessner

This decision, Appeal No. 2019-1149 (Fed. Cir. April 17th 2020) should have required about 13 pages and could have ended after the first paragraph under Section A. Instead, a split panel required a 23 page majority decision and a 10 … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment